New anti-Covid vaccine approved for autumn
A panel of advisors to the Food and Drug Administration voted Wednesday to update the COVID-19 vaccine formula ahead of a planned fall immunization campaign, now an annual step to try to offer better protection against circulating versions of the virus.The unanimous vote of 16 advisers recommends a formula aimed at combating the JN.1 variant, which dominated infections in the United States in February, or a version of it. In recent weeks, JN.1 has been overtaken by descendants known as KP.2 and KP.3.In the coming weeks, the FDA is expected to formally recommend a target variant to vaccine makers for the next round of vaccinations in late summer or early fall. Any decision involves some educated guesswork, given that any new vaccine formula won't be available until months after a vari...